(Reuters) – Health regulators added new warnings to the label of Forest Laboratories Inc‘s antidepressant Celexa and its generic versions about a potential risk of rare heart diseases.
The changed drug label has a particular caution for patients with certain conditions because of the risk of QT syndrome — a disorder of the heart’s electrical activity.
The FDA also said the maximum recommended dose of Celexa, or citalopram, is 20 mg per day for patients older than 60 years.
(Reporting by Kavyanjali Kaushik in Bangalore; Editing by Don Sebastian)
Related posts:
Cameraman decked at Thomas Kelly murder accused's hearing
Spanish Bailout Just “a Credit Line,” Says Spain’s New Prime Minister
Ontario woman recovering from lightning strike in Manitoba
Reuters's Freeland: 'Anorexic' Americans Think Tax Bite Too Heavy When In Fact It's Dangerously Thin
WikiLeaks suspect Manning presses for dismissal of charges
How to Distinguish Legitimate Truth-Tellers from Establishment Operatives